# EDGAR Filing Document

**Accession Number:** 0001177648
**File Stem:** 9999999995-26-000642
**Filing Date:** 2026-2
**Character Count:** 1242
**Document Hash:** d25df9a5dae54ecee93dd5e507aabc19
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**9999999995-26-000642.hdr.sgml**: 20260223

**ACCESSION NUMBER**: 9999999995-26-000642

**CONFORMED SUBMISSION TYPE**: EFFECT

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260220

**DATE AS OF CHANGE**: 20260223

**EFFECTIVENESS DATE**: 20260220

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ENANTA PHARMACEUTICALS INC
- **CENTRAL INDEX KEY:** 0001177648
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 043205099
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** EFFECT
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-293390
- **FILM NUMBER:** 26661947

**BUSINESS ADDRESS:**
- **STREET 1:** 4 KINGSBURY AVENUE
- **CITY:** WATERTOWN
- **STATE:** MA
- **ZIP:** 02472
- **BUSINESS PHONE:** 617 607 0800

**MAIL ADDRESS:**
- **STREET 1:** 4 KINGSBURY AVENUE
- **CITY:** WATERTOWN
- **STATE:** MA
- **ZIP:** 02472

### UNITED STATES
### SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## Notice of Effectiveness

**Date:** February 20, 2026

**Time:** 16:00:00

**Form Type:** S-3

---

**CIK:** 0001177648

**Company Name:** ENANTA PHARMACEUTICALS INC

**File Number:** 333-293390